We investigated the fingerprints of 48 batches of turmeric total extracts (TTE) by HPLC-MS-MS and GC-MS analyses and 43 characteristic peaks (22 constituents from HPLC-MS-MS; 21 from GC-MS) were analyzed qualitatively and quantitatively. An MTT {3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide} assay was implemented to measure the cytotoxicity of the TTE against HeLa cells. Then we utilized orthogonal partial least squares analysis, which correlated the chemical composition of the TTE to its cytotoxic activity, to identify potential cytotoxic constituents from turmeric. The result showed that 19 constituents contributed significantly to the cytotoxicity. The obtained result was verified by canonical correlation analysis. Comparison with previous reports also indicated some interaction between the curcuminoids and sesquiterpenoids in turmeric.
KimJ.H., GuptaS.C., ParkB., YadavV.R., AggarwalB.B. (2012) Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-kappa B and NF-kappa B-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. Molecular Nutrition & Food Research, 56, 454–465.
2.
MahadyG.B., PendlandS.L., YunG., LuZ. (2002) Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Research, 22, 4179–4181.
3.
KuttanR., BhanumathyP., NirmalaK., GeorgeM.C. (1985) Potential anticancer activity of turmeric (Curcuma longa). Cancer Letters, 29, 197–202.
4.
AzuineM.A., BhideS.V. (1992) Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutrition and Cancer17, 77–83.
5.
NiranjanA., PrakashD. (2008) Chemical constituents and biological activities of turmeric (Curcuma longa L.) - A review. Journal of Food Science and Technology-Mysore, 45, 109–116.
6.
ChakravartyA.K., YasminH. (2005) Alcoholic turmeric extract simultaneously activating murine lymphocytes and inducing apoptosis of Ehlrich ascitic carcinoma cells. International Immunopharmacology, 5, 1574–1581.
7.
AggarwalB.B., KumarA., BhartiA.C. (2003) Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Research, 23, 363–398.
8.
AdamsB.K., FerstlE.M., DavisM.C., HeroldM., KurtkayaS., CamalierR.F., HollingsheadM.G., KaurG., SausvilleE.A., RicklesF.R., SnyderJ.P., LiottaD.C., ShojiM. (2004) Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents. Bioorganic & Medicinal Chemistry, 12, 3871–3883.
9.
KunnumakkaraA.B., GuhaS., KrishnanS., DiagaradjaneP., GelovaniJ., AggarwalB.B. (2007) Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappa B-regulated gene products. Cancer Research, 67, 3853–3861.
10.
WiklundS., JohanssonE., SjostromL., MellerowiczE.J., EdlundU., ShockcorJ.P., GottfriesJ., MoritzT., TryggJ. (2008) Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Analytical Chemistry, 80, 115–122.
11.
BylesjoM., RantalainenM., CloarecO., NicholsonJ.K., HolmesE., TryggJ. (2006) OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. Journal of Chemometrics, 20, 341–351.
12.
JiangJ-L, JinX-L, ZhangH., SuX., QiaoB., YuanY-J. (2012) Identification of antitumor constituents in curcuminoids from Curcuma longa L. based on the composition-activity relationship. Journal of Pharmaceutical and Biomedical Analysis, 70, 664–670.
13.
JiangJ-L, DingH-T, SuX., YuanY-J. (2012) Identification of anti-tumor ingredients in curcuma volatile oil based on composition-activity relationship. Chinese Journal of Analytical Chemistry, 40, 1488–1493.
14.
JiangH.L., SomogyiA., JacobsenN.E., TimmermannB.N., GangD.R. (2006) Analysis of curcuminoids by positive and negative electrospray ionization and tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 20, 1001–1012.
15.
JiangH.L., TimmermannB.N., GangD.R. (2006) Use of liquid chromatography-electrospray ionization tandem mass spectrometry to identify diarylheptanoids in turmeric (Curcuma longa L.) rhizome. Journal of Chromatography A, 1111, 21–31.
16.
ZhouX., LiZ., LiangG., ZhuJ., WangD., CaiZ. (2007) Analysis of volatile components of Curcuma sichuanensis X. X. Chen by gas chromatography–mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 43, 440–444.
17.
QinN.Y., YangF.Q., WangY.T., LiS.P. (2007) Quantitative determination of eight components in rhizome (Jianghuang) and tuberous root (Yujin) of Curcuma longa using pressurized liquid extraction and gas chromatography–mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 43, 486–492.
18.
LiuY-X, ZhuX-L, ChenY-H, GuoF., ShenM., ChenZ-G, XuW., ChenD-Y, TaoZ-H. (2011) Metabolomic profiles in prostate cancer cells progression. Chinese Journal of Analytical Chemistry, 39, 305–311.
19.
CoxS.D., MannC.M., MarkhamJ.L. (2001) Interactions between components of the essential oil of Melaleuca alternifolia. Journal of Applied Microbiology, 91, 492–497.
20.
HemaiswaryaS., KruthiventiA.K., DobleM. (2008) Synergism between natural products and antibiotics against infectious diseases. Phytomedicine, 15, 639–652.
21.
Dalby-BrownL., BarsettH., LandboA.K.R., MeyerA.S., MolgaardP. (2005) Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human low-density lipoproteins. Journal of Agricultural and Food Chemistry, 53, 9413–9423.
22.
NishiyamaT., MaeT., KishidaH., TsukagawaM., MimakiY., KurodaM., SashidaY., TakahashiK., KawadaT., NakagawaK., KitaharaM. (2005) The effect of turmeric extracts on inflammatory mediator production. Journal of Agricultural and Food Chemistry, 53, 959–963.
